Answer
Taltz (ixekizumab) is indicated for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.
Sources for this answer
- Taltz 80 mg solution for injection in pre-filled penEli Lilly and Company Limited · emc · SmPC §4.1 Therapeutic Indications · Version 18Document updated
Sources checked